Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04294927 · ClinicalTrials.gov registry record · NA
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
A NA study of Ovarian Cancer and BRCA1 Gene Mutation, sponsored by University Medical Center Nijmegen.
- Recruiting
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
- 20
- Study locations
NCT04294927 is a NA study of Ovarian Cancer and BRCA1 Gene Mutation that is actively recruiting participants, run by University Medical Center Nijmegen. The registered enrollment target is 3,000 participants, above the 719-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (317% higher). The trial reports 20 study locations across 10 states.
The verdict
NCT04294927, a NA study of Ovarian Cancer and BRCA1 Gene Mutation, is actively recruiting participants, sponsored by University Medical Center Nijmegen.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The aim of the project is to evaluate the risk-reducing salpingectomy with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorectomy in high risk women with respect to ovarian cancer incidence.
Conditions Studied
Interventions
- PROCEDURE Risk-reducing salpingectomy with delayed oophorectomy
- PROCEDURE Risk-reducing salpingo-oophorectomy
Study Locations (20)
Other
- Monash Health - Melbourne
- Peter MacCallum Centre - Melbourne
- Royal Womens Hospital - Melbourne
- Hopital Universitaire Bruxelles - Brussels
- Universitair Ziekenhuis Leuven - Leuven
Victoria
- Frances Perry House - Melbourne
- Mercy Hospital - Melbourne
- Epworth Hospital - Richmon
- Western Health - St Albans
Queensland
- St Andrew War Memorial Hospital - Brisbane
- Royal Brisbane Hospital - Brisbane
- Greenslopes Private Hospital - Brisbane
New South Wales
- Chris O'Brien Lifehouse - Sydney
- Westmead hospital - Sydney
Massachusetts
- Dana Farber Cancer Institute - Boston
Minnesota
- Mayo Clinic - Rochester
Texas
- MD Anderson Cancer Centre - Houston
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2040-02-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04294927
The ClinicalTrials.gov registry entry for NCT04294927 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 719-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (317% higher). The listed sponsor is University Medical Center Nijmegen, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 2 interventions - of which Risk-reducing salpingectomy with delayed oophorectomy is the first listed.
NCT04294927 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Other, Victoria, Queensland.
Frequently Asked Questions
What is clinical trial NCT04294927 about?
NCT04294927 is a clinical study titled "TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention". The aim of the project is to evaluate the risk-reducing salpingectomy with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorectomy in high risk women with respect to ovarian cancer incidence.
What is the current status of trial NCT04294927?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2020-03-01. Estimated completion is 2040-02-17.
What conditions does trial NCT04294927 study?
This clinical trial studies the following conditions: Ovarian Cancer, BRCA1 Gene Mutation, BRCA2 Gene Mutation, BRIP1 Gene Mutation, RAD51C Gene Mutation.
What interventions are being tested in trial NCT04294927?
The interventions under investigation include: Risk-reducing salpingectomy with delayed oophorectomy (PROCEDURE), Risk-reducing salpingo-oophorectomy (PROCEDURE).
Who is sponsoring clinical trial NCT04294927?
This trial is sponsored by University Medical Center Nijmegen, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04294927 being conducted?
This trial has 20 study locations across Massachusetts, Minnesota, Texas, Washington, New South Wales. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
RECRUITING · NA
-
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
RECRUITING · NA
-
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.